CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

Biocon Limited announces the acquisition of a manufacturing facility of Eywa Pharma Inc.
  • Fri, 01-Sep-2023
  • Posted by: BIOCON
No Comments

Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%
  • Thu, 10-Aug-2023
  • Posted by: BIOCON
No Comments

Biocon Foundation and Shakti Sustainable Energy Foundation organize Cities and Climate Action Workshop
  • Wed, 09-Aug-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Announces Key Leadership Appointments
  • Fri, 04-Aug-2023
  • Posted by: BIOCON
No Comments

Biocon Foundation Releases Second Edition of Consensus Guidelines for Head & Neck Cancer
  • Thu, 27-Jul-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Announces Positive CHMP Opinion for YESAFILI®, Biosimilar Aflibercept
  • Mon, 24-Jul-2023
  • Posted by: BIOCON
No Comments

U.S. FDA Completes Two cGMP Inspections at Biocon Biologics Insulins Facility in Malaysia
  • Fri, 21-Jul-2023
  • Posted by: BIOCON
No Comments

Biocon Biologics Expands Footprint in Emerging Markets Takes Over the Commercialization of Biosimilars Business from Viatris in 70+ countries
  • Wed, 05-Jul-2023
  • Posted by: BIOCON
No Comments

After Five Years of Successful Experience Internationally, Biocon Biologics’ Hulio® Biosimilar to Humira®, Now Available in the United States
  • Mon, 03-Jul-2023
  • Posted by: BIOCON
No Comments

Biocon Group concluded the month-long sustainability initiatives commemorating ‘World Environment Day’ initiated with ‘Nature Positive’ Campaign
  • Fri, 30-Jun-2023
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2025, Biocon. All Rights Reserved
Share
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>